In this issue Drs Reid et al
1 describe correlations between low-level albumin excretion (microalbuminuria) and systolic blood pressure, diabetes and body weight in black hypertensive Jamaicans. They demonstrate that subjects with microalbuminuria have lower renal plasma flow and a higher filtration fraction.
This is yet another study showing association between microalbuminuria and established cardiovascular risk factors. However it is one thing to show associations between risk factors, and another to show that microalbuminuria is an independent marker of vascular risk which can be used to target patients for aggressive control of blood pressure, lipids, body weight and smoking etc, thereby reducing the incidence of cardiovascular events. This has not been shown to date.
Over 20 years ago Parving 2 demonstrated that urine albumin excretion correlated with both blood pressure and transcapillary escape rate of radiolabelled albumin in patients with essential hypertension. Increased systemic capillary permeability has also been linked with microalbuminuria in diabetes, 3 and recent studies suggest that endothelial dysfunction may lead to impaired insulin action and capillary leak of albumin: features which may be linked to a predisposition to cardiovascular disease. 4 Thus in addition to being an early marker of incipient diabetic nephropathy, urine albumin excretion is closely linked to vascular endothelial function by mechanisms which may represent common pathways for the development of both large and small vessel disease. 5 This makes microalbumin excretion an attractive candidate as a possible marker of vascular disease activity rather than simply a marker of cardiovascular risk.
However, the intimate relationship between lowlevel albumin excretion and vascular permeability makes urine albumin excretion very sensitive to the presence of any inflammatory process including cardiovascular disease. This is because one of the earl-iest features of inflammation is an increase in systemic vascular permeability, following for example, trauma, surgery, sepsis or in malignancy. 6 The kidneys are well placed to reflect small changes in vascular permeability since they receive 25% of the cardiac output which is filtered over a wide surface area. Since tubular reabsorption of the small amount of albumin which passes through glomerular filter is near maximal, 7 small increases in filtered albumin due to changes in systemic vascular permeability are amplified by the renal concentrating mechanisms producing relatively large changes in microalbumin excretion. 8 For similar reasons alterations in the fraction of plasma filtered by the glomerulus due to changes in blood pressure and intraglomerular pressure regulation may also cause relatively large changes in urine microalbumin content. It is therefore not surprising that several studies have shown microalbumin excretion to be positively correlated with blood pressure, especially at pressures Ͼ150/90 mm Hg. 2, 9 Thus microalbumin excretion reflects minute by minute changes in vascular endothelial permeability and has been found to be associated with many inflammatory processes such as bacterial meningitis, 10 rheumatoid arthritis, 11 inflammatory bowel disease, 12 acute pancreatitis, 13 trauma 14 and surgery. 15 In each condition microalbumin excretion is proportional to the severity of the condition, and since it occurs within minutes of acute insults, is of value in predicting later complications associated with interstitial oedema, such as acute respiratory distress syndrome. 16 Ischaemia and reperfusion is an important addition to this growing list. Microalbuminuria can be found within a few hours of acute myocardial infarction and is proportional to the size of the infarct. 17 Even small ischaemic episodes produce increased microalbumin excretion. For example, microalbuminuria is found in patients following positive exercise electrocardiogram tests, 18 and after exercise in patients with intermittent claudication. 19 In this latter group the degree of microalbuminuria is proportional to the severity of vascular disease and can be attenuated by surgical revascularisation. 20 What many studies of microalbuminuria and cardiovascular risk have failed to take into consideration is the exquisite sensitivity of albumin excretion to even mild inflammatory conditions. For example Agrawal et al 21 studied microalbumin excretion in 11 343 hypertensive patients, of whom 25% had coronary artery disease, 17% left ventricular hypertrophy, 5% stroke, and 6% peripheral vascular disease. In all disease categories urine microalbumin excretion was significantly higher than in patients without these conditions. The authors concluded that microalbumin measurements identifies hypertensive patients with cardiovascular risk. It is misleading to describe the presence of microalbuminuria as a cardiovascular risk factor in patients with established cardiovascular disease. Microalbuminuria which may have reflected a predisposition to cardiovascular disease is likely to have been overwhelmed by 'secondary' microalbuminuria associated with the inflammatory processes of ischaemia and reperfusion and atheromatous disease, in addition to the contribution from any other inflammatory conditions. This is not to discount the possibility that microalbumin excretion may identify populations at risk of developing vascular disease, but to emphasise the non-specific nature of the finding and the need for careful patient selection criteria. Observations of an association between microalbuminuria and insulin resistance in young adults suggest that these may predict cardiovascular disease in later life. 22, 23 Insertion/deletion polymorphism of the angiotensin-I converting (ACE) enzyme gene, leading to higher circulating activities of ACE and predisposition to cardiovascular disease, has been shown to be associated with microalbuminuria. 24 One possible mechanism linking microalbuminuria with the development of vascular diseases is loss of glomerular charge selectivity which has been found in both diabetic and non-diabetic populations with microaulbuminuria. 25 Urine albumin excretion in the general population reflects many processes including the effects of blood pressure, renal haemodynamics, inflammatory conditions such as ischaemia and reperfusion as well as renal disease. Inclusion of urine albumin measurement in screening programmes for vascular disease will yield a significant proportion of subjects with microalbuminuria, which will include subjects at various stages of vascular disease together with patients suffering other inflammatory conditions and renal disease. Perhaps this does not matter, if it can be shown that targeting these patients for risk factor reduction reduces the incidence of cardiovascular events. However until long term longitudinal studies have shown that microalbuminuria identifies patients at risk of developing cardiovascular disease, microalbuminuria should be regarded as a very sensitive index of inflammation, reflecting (in the absence of renal disease) vascular permeability, and that vascular disease is only one of a large number of inflammatory processes which can lead to microalbuminuria.
